Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
6.60
+0.07 (1.07%)
Oct 17, 2025, 9:40 AM EDT - Market open
Lifecore Biomedical Revenue
In the fiscal year ending May 25, 2025, Lifecore Biomedical had annual revenue of $128.87M with 0.47% growth. Lifecore Biomedical had revenue of $36.44M in the quarter ending May 25, 2025, a decrease of -3.81%.
Revenue (ttm)
$128.87M
Revenue Growth
+0.47%
P/S Ratio
1.76
Revenue / Employee
$317,406
Employees
406
Market Cap
247.28M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 25, 2025 | 128.87M | 606.00K | 0.47% |
| May 26, 2024 | 128.26M | 24.99M | 24.20% |
| May 28, 2023 | 103.27M | -8.00M | -7.19% |
| May 29, 2022 | 111.27M | 10.40M | 10.31% |
| May 30, 2021 | 100.87M | -59.19M | -36.98% |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 26, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 27, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
LFCR News
- 4 days ago - Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events - GlobeNewsWire
- 23 days ago - Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Lifecore Biomedical, Inc. (LFCR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference - GlobeNewsWire
- 6 weeks ago - Lifecore Biomedical to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Laughing Water Capital's Top 5 Positions For Q2 2025 - Seeking Alpha